Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CD73 Downregulation Decreases In Vitro and In Vivo Glioblastoma Growth
Juliana H. Azambuja, Nicolly Espindola Gelsleichter, Liziane Raquel Beckenkamp, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 5, pp. 3260-3279
Closed Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

Emerging therapies for glioblastoma: current state and future directions
Rong Liang, Ni Li, Zhenzhen Zhang
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 302
Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma
Sangeeta Goswami, Thomas Walle, Andrew Cornish, et al.
Nature Medicine (2019) Vol. 26, Iss. 1, pp. 39-46
Open Access | Times Cited: 296
Nucleic acid drug vectors for diagnosis and treatment of brain diseases
Zhiguo Lü, Jie Shen, H. J. Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 61
Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies
Atheer Khdyair Hamad, Gaukhar M. Yusubalieva, Владимир П. Баклаушев, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 547-547
Open Access | Times Cited: 58
Glioblastoma Microenvironment and Invasiveness: New Insights and Therapeutic Targets
José I. Erices, Carolina Bizama, Ignacio Niechi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7047-7047
Open Access | Times Cited: 57
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line
Alessio Malacrida, Mirko Rivara, Alessandro Di Domizio, et al.
Bioorganic & Medicinal Chemistry (2019) Vol. 28, Iss. 4, pp. 115300-115300
Closed Access | Times Cited: 121
Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy
Yuqing Cao, Xiaoyu Wang, Tianqiang Jin, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 121
Nasal Administration of Cationic Nanoemulsions as CD73-siRNA Delivery System for Glioblastoma Treatment: a New Therapeutical Approach
Juliana H. Azambuja, Roselena Silvestri Schuh, Luana Roberta Michels, et al.
Molecular Neurobiology (2019) Vol. 57, Iss. 2, pp. 635-649
Open Access | Times Cited: 85
Arginase-1+ Exosomes from Reprogrammed Macrophages Promote Glioblastoma Progression
Juliana H. Azambuja, Nils Ludwig, Saigopalakrishna S. Yerneni, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3990-3990
Open Access | Times Cited: 82
m6A RNA methylation and beyond – The epigenetic machinery and potential treatment options
Sabrina Garbo, Clemens Zwergel, Cecilia Battistelli
Drug Discovery Today (2021) Vol. 26, Iss. 11, pp. 2559-2574
Open Access | Times Cited: 74
Tumor-Associated Macrophages in Gliomas—Basic Insights and Treatment Opportunities
Johannes K. Andersen, Hrvoje Miletić, Jubayer A. Hossain
Cancers (2022) Vol. 14, Iss. 5, pp. 1319-1319
Open Access | Times Cited: 64
Nasal administration of a temozolomide-loaded thermoresponsive nanoemulsion reduces tumor growth in a preclinical glioblastoma model
Luana Roberta Michels, Flávia Nathiely Silveira Fachel, Roselena Silvestri Schuh, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 343-357
Closed Access | Times Cited: 26
Hypoxia within the glioblastoma tumor microenvironment: a master saboteur of novel treatments
Lisa Feldman
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Adenosinergic Signalling in Cervical Cancer Microenvironment
Isabele Cristiana Iser, Ana Paula Santin Bertoni, Liziane Raquel Beckenkamp, et al.
Expert Reviews in Molecular Medicine (2025) Vol. 27
Closed Access | Times Cited: 1
Adenosine Blockage in Tumor Microenvironment and Improvement of Cancer Immunotherapy
Samaneh Arab, Jamshid Hadjati
Immune Network (2019) Vol. 19, Iss. 4
Open Access | Times Cited: 73
Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration
Martina Ott, Karl-Heinz Tomaszowski, Anantha Marisetty, et al.
JCI Insight (2020) Vol. 5, Iss. 17
Open Access | Times Cited: 53
CD73-positive extracellular vesicles promote glioblastoma immunosuppression by inhibiting T-cell clonal expansion
Ming Wang, Jiaoying Jia, Yan Cui, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 11
Open Access | Times Cited: 53
Regulation of immune responses through CD39 and CD73 in cancer: Novel checkpoints
Elham Baghbani, Saeed Noorolyai, Dariush Shanehbandi, et al.
Life Sciences (2021) Vol. 282, pp. 119826-119826
Closed Access | Times Cited: 44
The Role of Immune Checkpoint Molecules on Macrophages in Cancer, Infection, and Autoimmune Pathologies
Victoria C. Brom, C. Burger, Dieter Christian Wirtz, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 29
Inhibition of the Adenosinergic Pathway in Cancer Rejuvenates Innate and Adaptive Immunity
Juliana H. Azambuja, Nils Ludwig, Elizandra Braganhol, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 22, pp. 5698-5698
Open Access | Times Cited: 47
Single-Cell Approaches to Profile the Response to Immune Checkpoint Inhibitors
Lara Gibellini, Sara De Biasi, Camillo Porta, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 47
Blockade of CD73 delays glioblastoma growth by modulating the immune environment
Juliana H. Azambuja, Roselena Silvestri Schuh, Luana Roberta Michels, et al.
Cancer Immunology Immunotherapy (2020) Vol. 69, Iss. 9, pp. 1801-1812
Open Access | Times Cited: 47
Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1
Valentina Lulli, Mariachiara Buccarelli, Ramona Ilari, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3610-3610
Open Access | Times Cited: 41
Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro and in vivo
Armin Mahmoud Salehi Khesht, Vahid Karpisheh, Parisa Sahami Gilan, et al.
International Journal of Biological Macromolecules (2021) Vol. 186, pp. 849-863
Closed Access | Times Cited: 35
Rational design of siRNA-based delivery systems for effective treatment of brain diseases
Dailin Lu, Yonghang Sun, Yuxia Luan, et al.
Pharmaceutical Science Advances (2024) Vol. 2, pp. 100041-100041
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top